Found 0 matching trials
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer PHASE2 Determine anti-tumor efficacy by characterizing response rates on positron ...
Show More Location
Montefiore Einstein Comprehensive Cancer Center (MECCC)
Learn More & Join Trial
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer N/A Non-muscle-invasive bladder cancer (NMIBC) has a high rate of recurrence (6...
Show More Location
Centre Hospitalier Universitaire de Bordeaux
Learn More & Join Trial
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer PHASE2 The purpose of this study is to evaluate the safety and clinical activity o...
Show More Location
Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression PHASE1 This is a single-arm, exploratory phase Ib/II study with a seamless design ...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) N/A Observational, multicentre, retrospective study on patients taken care acco...
Show More Location
Centre Hospitalier D Argenteuil
Learn More & Join Trial
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China PHASE2 Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Show More Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Learn More & Join Trial
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors PHASE2 This is an open-label, multicenter, basket trial Phase II study to evaluate...
Show More Location
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) PHASE2 Open-label, non-randomized, phase II multi-centre controlled clinical trial...
Show More Location
Hospital General Universitario de Alicante
Learn More & Join Trial
Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants. PHASE2 This is an open-label, multicenter, Phase II clinical study to evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients PHASE2 This phase II study will explore the effect of 2 monoclonal antibodies, tir...
Show More Location
Border Medical Oncology Research Unit
Learn More & Join Trial